News Focus
News Focus
icon url

cacher

08/21/05 6:33 PM

#22442 RE: Paulness #22441

Very Suite...I hope one of them knows how to market a product other than stock...if not they should just hire more lawyers.....
icon url

Paulness

08/21/05 10:19 PM

#22443 RE: Paulness #22441

I really like this part.

Dr. Malcolm Skolnick, CytoGenix President and CEO commented, "This is the next step in our march to make pharmaceutical grade DNA affordable. This is truly a breakthrough technology that changes the economics of cost-sensitive products such as DNA vaccines, antimicrobials and cancer immunotherapy. In the next few years, this technology will drive the development of DNA therapeutics for human and animal application by significantly reducing the costs of finished products